WallStSmart

Webull Corp (BULL)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Webull Corp generates 118% more annual revenue ($564.33M vs $258.90M). BULL leads profitability with a 4.4% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

BULL

Avoid

34

out of 100

Grade: F

Growth: 6.7Profit: 4.0Value: 4.7Quality: 5.0
Piotroski: 3/9Altman Z: -0.63

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BULLOvervalued (-7.0%)

Margin of Safety

-7.0%

Fair Value

$5.83

Current Price

$6.76

$0.93 premium

UndervaluedFair: $5.83Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BULL2 strengths · Avg: 9.5/10
Revenue GrowthGrowth
54.5%10/10

Revenue surging 54.5% year-over-year

Debt/EquityHealth
0.129/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

BULL4 concerns · Avg: 3.0/10
Return on EquityProfitability
3.0%3/10

ROE of 3.0% — below average capital efficiency

Profit MarginProfitability
4.4%3/10

4.4% margin — thin

Operating MarginProfitability
2.4%3/10

Operating margin of 2.4%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : BULL

The strongest argument for BULL centers on Revenue Growth, Debt/Equity. Revenue growth of 54.5% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : BULL

The primary concerns for BULL are Return on Equity, Profit Margin, Operating Margin. Thin 4.4% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

BULL is growing revenue faster at 54.5% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 34/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Webull Corp

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Webull Corporation is a digital investment platform. The company is headquartered in St. Petersburg, Florida.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?